|
|
Line 31: |
Line 31: |
| |style="background:#ffffff"| | | |style="background:#ffffff"| |
|
| |
|
| <font size="3">'''Rexxi Prasasya'''</font size> | | <font size="3">'''Rexxi Prasasya'''</font size><br> |
| | | <font size="2">Biomedical Engineering <br> |
| <font size="2">Second year <br>
| | Second Year<br> |
| Biomedical Engineering<br>
| | Project: Sensitivity of Ovarian Cancer to <br> |
| Project: ERBB inhibitor sensitivity in ovarian cancer<br>
| | ERBB Inhibitors<br> |
| |}
| | <br> |
| {|cellspacing="1" cellpadding="3" style="background:#ffffff; width: 500px;"
| |
| | |
| |style="background:#ffffff"|
| |
| [[Image:Dawn_Tian.jpg|200px]]
| |
| |style="background:#ffffff"|
| |
| | |
| <font size="3">'''Dawn Tian'''</font size>
| |
| | |
| <font size="2">Second year <br> | |
| Biomedical Engineering<br> | |
| Project: Estrogen and phytoestrogen signaling in breast cancer<br>
| |
| |}
| |
| | |
| ==Undergraduate Students==
| |
| | |
| {|cellspacing="1" cellpadding="3" style="background:#ffffff; width: 500px;"
| |
| | |
| |style="background:#ffffff"|
| |
| [[Image:KatiePollock.jpg|200px]]
| |
| |style="background:#ffffff"|
| |
| | |
| <font size="3">'''Katie Pollock'''</font size>
| |
| | |
| <font size="2">Senior <br>
| |
| Biomedical Engineering<br>
| |
| Project: Inflammation in endometriosis<br> | |
| | |
| <br>
| |
| | |
| | |
| | |
| | |
| <br> | |
| </font size>
| |
| |}
| |
| {|cellspacing="1" cellpadding="3" style="background:#ffffff; width: 500px;"
| |
| | |
| |style="background:#ffffff"|
| |
| [[Image:Vovos.jpg|200px]]
| |
| |style="background:#ffffff"|
| |
| | |
| <font size="3">'''Tyler Vovos'''</font size>
| |
| | |
| <font size="2">Senior <br>
| |
| Biomedical Engineering<br>
| |
| Project: ERBB receptor ligands in ovarian cancer<br>
| |
| | |
| <br> | |
| | |
| | |
| | |
| | |
| <br> | |
| </font size>
| |
| |}
| |